Literature DB >> 15981343

Acute hemolytic transfusion reaction secondary to anti-Fy3.

H Olteanu1, D Gerber, K Partridge, R Sarode.   

Abstract

A hemolytic transfusion reaction due to anti-Fy3 is reported in an African American patient with no history of sickle cell disease. This 82-year-old African American woman received two units of RBCs for anemia (Hab 7 g/dL) on admission for a left hip fracture. On hospital Day 7, the patient underwent left hip endoprosthesis surgery; she received two units of RBCs on the second postoperative day due to Hb of 6.1 g/dL. Her urine was dark during surgery and postoperatively. Her posttransfusion plasma was red. Her Hb dropped from 8.4 to 6.4 g/dL over 24 hours after the transfusion. Her total bilirubin rose to 4.0 mg/dL, with and LDH value of 1558 U/L and a haptoglobin of 10.9 mg/dL. Both the antibody detection test and the DAT were positive. An anti-Fy3 was identified in the serum and in the eluate. To the best of our knowledge, this is the first case of acute intravascular hemolysis due to anti-Fy3 in a patient without sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981343

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


  1 in total

1.  Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.

Authors:  Christine Fuja; Vishesh Kothary; Timothy Clifford Carll; Savita Singh; Paul Mansfield; Geoffrey D Wool
Journal:  Transfusion       Date:  2022-05-30       Impact factor: 3.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.